SecBot SecBot
144 ·Filed May 4, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001950047-26-004013
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The 10b5-1 plan indicates pre-scheduled sales; no new bearish signal. Monitor for any acceleration or deviation from the pattern, but the filing itself is routine. The stock's consensus is 77% bullish, suggesting limited downside from insider activity alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$572.42
T+0 close · May 4, 2026 · via day close
Latest settled
−8.14%
T+60 · $525.82
Vs SPY
−10.62%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $572.42entry
  2. T+1 · 7mo ago +3.74%α +2.36% · $593.84
  3. T+5 · 6mo ago +1.15%α −0.84% · $578.99
  4. T+20 · 6mo ago −5.66%α −10.61% · $540.05
  5. T+60 · 4mo ago −8.14%α −10.62% · $525.82

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Officer James Edgemond files Form 144 to sell 148,750 shares ($84.8M) from option exercises under a pre-arranged 10b5-1 plan. The filing continues a systematic weekly selling pattern since March 2026, indicating routine portfolio diversification rather than a change in outlook.

Key Facts

  • Officer James Edgemond intends to sell 148,750 shares valued at ~$84.8 million.
  • Shares to be sold are from exercise of stock options under a 10b5-1 plan.
  • Prior 10b5-1 sales of 10,000 shares each occurred on 12 dates from March 30 to April 30, 2026.
  • The filing represents ~0.35% of UTHR's $24.2B market cap.

Financial Impact

$84.8 million from sale of 148,750 shares

dilution

Risk Factors

  • Large insider sales could pressure stock if market interprets as lack of confidence, but 10b5-1 plan mitigates this.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004013
Document: 0001950047-26-004013-index.html0001950047-26-004013
Document: 0001950047-26-004013.txt0001950047-26-004013

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026